Literature DB >> 33430302

Overview of the Motivation of Advance Care Planning: A Study from a Medical Center in Taiwan.

Yi-Jhen He1, Ming-Hwai Lin1,2, Jo-Lan Hsu1, Bo-Ren Cheng1,2, Tzeng-Ji Chen1,2, Shinn-Jang Hwang1,2.   

Abstract

(1) Background: Since Taiwan's Patient Right to Autonomy Act took effect in 2019, up to ten thousand declarants have participated in advance care planning (ACP) and have signed advance directives (ADs). Relative to the entire population of Taiwan, only a small percentage have completed ACP. This study sought to understand the motivations of Taiwanese who have participated in ACP, so as to increase the percentage of individuals participating in ACP and signing ADs; (2)
Objectives: To understand the motivations that drive Taiwanese individuals to participate in ACP discussions.; (3)
Methods: A retrospective secondary data analysis was performed in this study. The participants consisted of declarants who completed their ACP at a medical center in Taiwan in 2019; (4)
Results: During the study period, 946 individuals completed their ACP. Of those declarants, 66.7% were over 60 years of age; 66.5% completed the process in groups of three or more; 49.5% completed their ACP free of charge; and 35 declarants had designated a health care agent (HCA). The declarants' four main motivations for participating in ACP were "looking forward to dying with dignity," "making end-of-life preparations," "fear of being a social and economic burden on family members," and "reluctance to let family members take on the responsibility of making decisions." Furthermore, statistically significant differences were observed between the declarants in terms of gender, age, designation of an HCA, and motivations for participating in ACP. Females, declarants aged below 60 years, and declarants with a designated HCA tended to participate in ACP due to "reluctance to let family members to take on the responsibility of making decisions". Males, declarants aged above 60 years, and declarants without an HCA came for ACP because of "fear of being a social and economic burden on family members". (5) Conclusions: The main motivations of Taiwanese individuals who sought ACP were to die with dignity and to have an early understanding of end-of-life treatment and care models. Secondly, these individuals hoped that their families would not have to take on the responsibility of making decisions. They also did not want to impact their families socially and economically. In this regard, providing economic subsidies might enhance the Taiwanese public's intentions to seek ACP discussions on their own initiative.

Entities:  

Keywords:  Taiwan; advance care planning; advance directives; health care agent; motivation

Year:  2021        PMID: 33430302      PMCID: PMC7825806          DOI: 10.3390/ijerph18020417

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  33 in total

Review 1.  Advance care planning and the older patient.

Authors:  D Aw; B Hayhoe; A Smajdor; L K Bowker; S P Conroy; P K Myint
Journal:  QJM       Date:  2011-11-10

2.  Physicians' Views on Advance Care Planning and End-of-Life Care Conversations.

Authors:  Terry Fulmer; Marcus Escobedo; Amy Berman; Mary Jane Koren; Sandra Hernández; Angela Hult
Journal:  J Am Geriatr Soc       Date:  2018-05-23       Impact factor: 5.562

3.  Experts practice what they preach: A descriptive study of best and normative practices in end-of-life discussions.

Authors:  D L Roter; S Larson; G S Fischer; R M Arnold; J A Tulsky
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

4.  The effect of a social work intervention to enhance advance care planning documentation in the nursing home.

Authors:  R Sean Morrison; Eileen Chichin; John Carter; Orah Burack; Melinda Lantz; Diane E Meier
Journal:  J Am Geriatr Soc       Date:  2005-02       Impact factor: 5.562

5.  Decision-Making Processes in Surrogates of Cancer Patients in a Taiwan Intensive Care Unit.

Authors:  Wan-Na Sun; Hsin-Tien Hsu; Nai-Ying Ko; Yu-Tung Huang
Journal:  Int J Environ Res Public Health       Date:  2020-06-20       Impact factor: 3.390

6.  Advance care planning after hospital discharge: qualitative analysis of facilitators and barriers from patient interviews.

Authors:  Vanessa Peck; Sabira Valiani; Peter Tanuseputro; Sunita Mulpuru; Kwadwo Kyeremanteng; Edward Fitzgibbon; Alan Forster; Daniel Kobewka
Journal:  BMC Palliat Care       Date:  2018-12-05       Impact factor: 3.234

7.  Shared decision making with oncologists and palliative care specialists effectively increases the documentation of the preferences for do not resuscitate and artificial nutrition and hydration in patients with advanced cancer: a model testing study.

Authors:  Hsien-Liang Huang; Jaw-Shiun Tsai; Chien-An Yao; Shao-Yi Cheng; Wen-Yu Hu; Tai-Yuan Chiu
Journal:  BMC Palliat Care       Date:  2020-02-04       Impact factor: 3.234

Review 8.  Barriers and facilitators for general practitioners to engage in advance care planning: a systematic review.

Authors:  Aline De Vleminck; Dirk Houttekier; Koen Pardon; Reginald Deschepper; Chantal Van Audenhove; Robert Vander Stichele; Luc Deliens
Journal:  Scand J Prim Health Care       Date:  2013-12       Impact factor: 2.581

9.  Current Engagement in Advance Care Planning in Japan and Its Associated Factors.

Authors:  Megumi Inoue; Kyoko Hanari; Jun Hamano; Joshua Gallagher; Nanako Tamiya
Journal:  Gerontol Geriatr Med       Date:  2019-12-20
View more
  2 in total

1.  Exploring Differential Perceptions and Barriers to Advance Care Planning in Dementia among Asian Patient-Caregiver Dyads-A Mixed-Methods Study.

Authors:  Noorhazlina Ali; Philomena Anthony; Wee Shiong Lim; Mei Sian Chong; Edward Wing Hong Poon; Vicki Drury; Mark Chan
Journal:  Int J Environ Res Public Health       Date:  2021-07-04       Impact factor: 3.390

2.  Predictors and Assessment of Hospice Use for End-Stage Renal Disease Patients in Taiwan.

Authors:  Hung-Cheng Chen; Chien-Yi Wu; Hui-Ya Hsieh; Jiun-Shiuan He; Shang-Jyh Hwang; Hui-Min Hsieh
Journal:  Int J Environ Res Public Health       Date:  2021-12-22       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.